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a b s t r a c t
Intravascular ultrasound (IVUS), optical coherence tomography (OCT) and near infrared
spectroscopy (NIRS) allows for a thorough analysis of the atheroma's morphology in vivo.
Moreover, it helps to guide coronary intervention and assess the results of stenting. IVUS,
OCT and NIRS provide unique data about the analyzed tissue and thus all of them comple-
ment each other. Their application in daily clinical practice helps to understand the
underlying pathology of disease and may contribute to the improvement of outcomes in
coronary interventions.
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reserved.
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Introduction
The introduction of intravascular imaging opened new
horizons for the presentation of coronary atherosclerosis
in vivo. It became possible to follow the development of
atherosclerosis and to detect atheromas that are prone to
rupture (vulnerable plaques) known as thin ﬁbrous cap
atheromas (TCFA). Moreover, intravascular imaging helps to
guide coronary interventions and to assess their results.
Nowadays, available intravascular imaging modalities utilize
ultrasound and near infrared light (niR). Due to their intrinsic
properties, both ultrasound and niR deliver unique informa-
tion about the analyzed tissue and thus complement each
other. The following review presents the basics of intravascu-
lar ultrasound (IVUS), optical coherence tomography (OCT)
and niR spectroscopy (NIRS) in terms of plaque description,
percutaneous coronary intervention (PCI) guidance and clini-
cal application.
Intravascular ultrasound
The intravascular ultrasound (IVUS) is an invasive imaging
modality that utilizes ultrasound (20–40 MHz) to present the
vessel wall [1]. The dedicated IVUS catheter is advanced into
the coronary vessel over a guidewire. The procedure is usually
performed as part of standard invasive diagnostic coronary
angiography. The IVUS probe is pulled back in the coronary
vessel with a constant speed (1 or 0.5 mm/s) and simulta-
neously provides gray-scale cross-sectional and longitudinal
images of the analyzed vessel. The axial resolution of IVUS
ranges from 100 to 200 mm, which allows presenting three
layers of the vessel at cross-sectional images: intima, media
and adventitia. The lumen area, vessel area, plaque burden
(the amount of plaque that occupies vessel area) and plaque
volume are estimated by IVUS (Fig. 1). Moreover, the IVUS
longitudinal analysis describes vessel remodeling. If the
maximal vessel area within the plaque is higher then the
vessel reference area, the positive vessel remodeling occurs. If
maximal vessel area is lower than the vessel size, the lesion is
classiﬁed as negatively remodeled [2]. Nevertheless, the
plaque composition is roughly estimated by gray-scale IVUS.
The echo-lucent plaque with shadowing is described as
calciﬁed [3] whereas plaques with low echogenity are
described as soft and their composition remains unclear [4]
Fig. 1 – Representative images of intravascular ultrasound
(IVUS). (A) Cross-sectional gray-scale IVUS (40 MHz probe)
image of the healthy segment of coronary artery presenting
the intima (In), the media (M) and the adventitia (Ad). (B)
Cross-sectional gray-scale IVUS (40 MHz probe) image of
the soft plaque (white arrow). (C) Cross-sectional gray-scale
IVUS (40 MHz probe) image of calcification (white arrow).
(D) Cross-sectional virtual histology IVUS image (20 MHz
probe) of thick fibroatheroma. Plaque burden is a space
between the yellow line and red line expressed as
percentage of area bordered by red line. (E) Cross-sectional
gray-scale IVUS (20 MHz probe) image after stent
implantation presenting appropriate stent struts
apposition (white arrows).
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More precise analysis of soft plaque composition by IVUS is
derived by spectral analysis of its signal, known as Virtual
Histology (VH-IVUS). VH-IVUS identiﬁes 4 different types of
plaque components: ﬁbrous (green), ﬁbro-fatty (yellow), dense
calcium (white) and necrotic core (red) [5] (Fig. 1). Its accuracy
has been documented by in vivo and in vitro studies. Moreover,
VH-IVUS is able to detect thin ﬁbrous cap atheroma (TCFA).
TCFA is covered with ﬁbrous cap less then 65 mm thick and
IVUS resolution does not allow for direct measurement of cap
thickness. Hence, the plaque is recognized as TCFA by VH-
IVUS if the necrotic core (red color) has a direct contact with
the lumen and occupies more then 40% of the plaque in 3
consecutive cross-sectional images. The PROSPECT studyshowed that the presence of such recognized TCFA increases
the risk of future coronary events [6]. However, the results of
the PROSPECT study should be discussed in light of contro-
versies around precision of VH-IVUS. The histology data
suggested poor accuracy of VH-IVUS in the necrotic core
detection [7].
For many years IVUS imaging also served as a tool to
estimate the signiﬁcance of the intermediate coronary artery
stenosis. The cut-off value of lumen area for non-left main
(LM) stenosis was 4 mm2 [8]. However, reports comparing the
results of FFR and IVUS suggested that such cut-off value
should be less then 3.07 mm2 in non-LM stenosis, and less
then 5.5 mm2 in LM stenosis [9]. Nowadays, it is only
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and despite the results of FFR studies clinical observations
suggest that 6 mm2 lumen area is the most appropriate cut-off
value [10].
IVUS also helps to guide coronary interventions. Obtained
measurements of the treated plaque facilitate the choice of
appropriate stent diameter and length, and to assess the
results of stenting (Fig. 1). IVUS easily presents stent under-
expansion, stent malapposition and vessel dissection – three
main risk factors for the acute stent thrombosis [11]. It is
suggested that the optimal minimal DES area should be more
than 8 mm2 in LM, more than 6 mm2 in proximal segment of
LAD, and more than 5 mm2 in proximal segment of Cx post
procedure [12]. IVUS guided PCI signiﬁcantly decreases all-
cause mortality in both left main and non-left main stenting
[13–15].
Optical coherence tomography
Similarly to IVUS, OCT provides cross-sectional images of the
vessel. Instead of ultrasound OCT utilizes niR to present the
morphology of the vessel; niR wavelength ranges between
1250 and 1350 nm. niR is split in two paths and the signal is
obtained from the interference of the light backscattered from
the analyzed tissue with the light backscattered from the
reference mirror [16]. Initially OCT imaging used time-domain
(TD) slow analysis of the interference signal. Currently it has
been replaced with much faster frequency domain (FD)
analysis, which signiﬁcantly speed up the imaging process
[17].
As opposed to the IVUS imaging, the utilization of niR for
OCT imaging requires blood removal from the vessel at the
time of imaging, as the wavelength of niR does not penetrate
through red blood cells. First TD OCT systems required
coronary artery occlusion at the time of imaging, which
increased the risk of life threating arrhythmias. The now-
available FD-OCT imaging systems are so fast that the
procedure may be performed at the time of a 3 s long injection
of the contrast agent [18], which makes the procedure much
safer [19].
OCT system is composed of the workstation and intravas-
cular catheters with the OCT probe. The catheters are
monorail systems and are advanced over a guidewire to the
coronary artery. At the time of imaging the contrast is injected
to ﬂush the blood away and the probe is pulled back from
distal segment to proximal segment of the artery. OCT
imaging lasts 2.7 s and presents from 54 (10 mm step) to
72 mm (13 mm step) of the vessel length during the single
pullback of the probe.
The use of light signiﬁcantly improved the resolution of
intravascular imaging. It ranges between 10 and 20 mm.
However, the improved resolution is at the cost of beam
penetration into the vessel wall. It obtains a signal only from 1
to 3 mm of the vessel wall, and thus does not allow to present
plaque burden, and consequently plaque volume and vessel
remodeling [17].
Nevertheless, similarly to IVUS, OCT provides quantitative
analysis of the vessel lumen and OCT automated contour
detection is very accurate and allows a very precisemeasurement of lumen area, lumen diameter and length of
region of interest. Moreover, a novel OCT system (iLumien
Optis, St. Jude Medical) provides an automated three-
dimensional reconstruction of the analyzed segment (Fig. 2),
which is overlaid on the angiography image to precisely guide
PCI [20].
In healthy segments of coronary artery OCT presents four
layers of the arterial wall: inter-elastic lamina, media, external
elastic lamina and adventitia (Fig. 2). At the site of atheroma
OCT is able to distinguish lipid, ﬁbrotic and calciﬁed
components of the analyzed tissue. The lipid is characterized
by high signal attenuation with the diffuse edges, calcium – by
signal-poor area with sharp borders, and ﬁbrotic components
are presented as homogenous tissue with high reﬂectivity [21].
The high accuracy of plaque composition delivered by OCT
was conﬁrmed by histology [22] (Fig. 2). OCT is also able to
present thrombus (and differentiate white thrombus from red
one), intimal tear, intramural hematoma, micro vessels, and
macrophage [17].
Thanks to high resolution of OCT imaging it became
possible to directly measure the thickness of the ﬁbrotic cap
covering the lipid core and thus to detect TCFA. It makes OCT
the gold standard to detect vulnerable plaques [23] (Fig. 2).
High resolution of OCT imaging enables to present the
results of coronary intervention with the unprecedented
precision. The stent strut malapposition, stent under-expan-
sion and vessel dissection are very clearly presented by OCT.
Due to light properties, metallic struts are only visible at their
adluminal edge, and the knowledge about the strut thickness
is necessary for stent apposition assessment. If the distance
between the middle of the blooming struts and the vessel
contour is more than the strut thickness, the malapposition is
detected [24] (Fig. 2). Contrary to metallic stents, the whole
polymeric struts of bioresorbable vascular scaffolds (BVS) are
presented by OCT and malapposition is easily detected as a
gap between the scaffold and the vessel contour. BVS imaging
by OCT is also able to present a scaffold disruption, which is
not possible to detect by ﬂuoroscopy [25]. Notably, OCT is the
only method that can appropriately assesses the expansion of
BVS.
In addition to the stent apposition, OCT presents plaque
protrusion through stent struts and thrombus formation.
OCT has been broadly applied in the assessment of vessel
healing after stent implantation. It perfectly presents stent
struts coverage by neointima and provides neointima charac-
teristic [26]. The heterogenous, layered, homogenous and lipid
rich neointima may be described by OCT within implanted
stent and at follow-up. The lack of homogenous neointima is
associated with poorer clinical outcome [27]. Lipid-rich
neointima indicates the presence of neoatherosclerosis within
the stent, the heterogenous neointima is associated with high
amount of ﬁbrin, and layered neointima with persistent peri-
struts inﬂammation [28].
OCT imaging also provides new approach in the treatment
of myocardial infraction. It distinguishes between plaque
rupture and plaque erosion as a cause of vascular thrombosis.
Initial clinical observations suggest that eroded plaque may be
subjected only to thrombectomy and left unstented without
any major adverse cardiac events observed during the long-
term follow-up [29].
Fig. 2 – Representative images of intravascular optical coherence imaging (OCT). (A) Cross-sectional OCT image of healthy
segment of coronary vessel presenting the internal elastic lamina (IEL), the media (M), external elastic lamina (EEL) and
adventitia (AD). (B) Cross-sectional OCT image of fibrotic lesions. (C) Cross-sectional OCT image of lipid-rich lesion covered
with thin fibrous cap atheroma (TCFA – white arrows). The image presents also small red thrombi. (D) Cross-sectional OCT
image of calcification (white arrow). (E) Cross-sectional OCT image after the implantation the everolimus eluting stent with
visible stent struts in malapposition (white arrows). (F) Cross-sectional OCT image post implantation of bioabsorbable
vascular scaffold with visible polymeric struts. (G) Three-dimensional reconstruction of coronary artery at the site of stent
impanation.
Fig. 3 – Representative image of intravascular near infrared
spectroscopy (NIRS) combine with IVUS image. The figure
presents NIRS map with detected lipids (yellow color) and
the NIRS block chemogram. Black pixels present the region
with not enough data to analysis. Green dashed arrows
presents the segment of the vessel with the highest lipid
core burden index = 283. The white dashed line
corresponds to the cross-sectional image of IVUS with
overlayed NIRS map as a colorful ring.
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NIRS utilizes niR in a range between 780 and 2500 mm to
analyze the molar absorptivity of the tissue. Since light is
absorbed with a different degree for every single particle, NIRS
is able to present the chemical composition of the analyzed
object. NIRS has been introduced into coronary imaging as
modality focused on the detection of lipid deposition within
the vessel [30]. As opposed to OCT, the applied wavelength of
niR does not require blood removal from the vessel lumen to
perform the analysis. Moreover, the intravascular NIRS is the
only tool to assess tissue composition through the eyes of the
implanted stent struts [31].
Similar to OCT and IVUS, the NIRS system is composed of
an off-line station and intravascular catheters, which contain
NIRS probe. NIRS probe is advanced into region of interest and
pulled back with a speed 0.5 mm/s. NIRS penetration into the
vessel wall is about 1 mm. Raw spectra of NIRS are decoded
into a 7-digit color map and a 7-digit color block chemogram. A
lipid distribution over the vessel is presented as yellow, tan
and orange pixels whereas red pixels indicate its absence. If a
pixel does not contain enough data (e.g. as caused by a
guidewire), it appears black. The X-axis on the NIRS map
presents the length of the pullback and the Y-axis on the map
presents vessel circumference in 0–3608 (Fig. 3).NIRS mapping allows calculation of lipid core burden index
(LCBI). It is a rate of all yellow pixels within the analyzed
segment and is expressed per mille. LCBI is calculated for the
total length of the region of interest, and the 4 mm segment
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block chemogram presents the probability of lipid deposition
within 2 mm segments. For both NIRS map and NIRS
chemogram the yellow indicates >0.97, tan indicates 0.84–
0.97, orange indicates 0.57–0.83 and red indicates < 0.57
probability of lipid deposition. In summary, NIRS map is a
very simple picture with lipids presented as yellow pixels on
the red background. The presentation of lipid deposition by
NIRS map and block chemogram has been validated by the
histology [32] (Fig. 3).
In current practice NIRS has been only applied for research
purposes and does not have any clinical application. YELLOW
study found that with the use of NIRS one may observe
chemical reconstruction of the plaque subjected to aggressive
lipid-lowering therapy [33]. COLOR registry suggested that
stenting of lesions with LCBI4mm > 500 constitutes a risk of
peri-procedural myocardial infarction [34], but CANARY did
not ﬁnd any beneﬁts to patients from the use of distal
protection devices during PCI of lesion with LCBI4mm > 600
[35,36]. The on-going LRP study is aimed to estimate whether
NIRS coronary imaging may help to predict the future coronary
events.
Finally, NIRS probe has been combined with the gray-
scale IVUS to present the morphology of the lesion more
precisely (Fig. 3). It is now the only hybrid intravascular
imaging catheter available on the market. The results of IVUS
and NIRS imaging are overlaid against each other and the
combined IVUS and NIRS cross-sectional image is displayed.
The NIRS ring at the cross-sectional NIRS–IVUS image
corresponds to the location at the NIRS map (Fig. 3). The
combination of both modalities enriched the gray-scale IVUS
analysis with NIRS. Results from the histology showed that
combined IVUS–NIRS analysis poses a high accuracy in
detection of ﬁbroatheromas [4]. On the other hand clinical
observation suggested that NIRS–IVUS made possible detec-
tion of OCT deﬁned TCFA as positively remodeled vessel with
LCBI2mm > 315 [37].
IVUS vs. OCT vs. NIRS
As opposed to IVUS, OCT requires blood removal from the
vessel at the time of imaging. It does not allow for ostial lesion
assessment. Moreover, OCT requires additional contrast
injection and should be used with caution in patients with
renal insufﬁciency. Smaller diameters and lumen areas are
also provided by OCT as compared to IVUS measurements. The
difference falls between 10% and 20%; thus IVUS cut-off values
of lumen area cannot be used in OCT imaging to assess
signiﬁcance of coronary stenosis [38].
In terms of lipid detection, NIRS and OCT correlate
moderately [39] and NIRS and VH-IVUS correlate poorly [40].
The correlation between NIRS and VH-IVUS is also poor in
calciﬁed lesions [36]. On the other hand, the comparison of
TCFA detection by VH-IVUS with OCT deﬁned TCFA show that
VH-IVUS overestimate the number of vulnerable plaques [41].
Finally, the analysis from multimodality imaging (OCT,
IVUS, NIRS) suggests that OCT derived TCFA is the strongest
predictor of distal embolization as compared do LCBI values
and plaque burden [42].Conclusion
Every intravascular imaging modality offers quantitative
analysis of the lesion and implanted stent, and provides
unique information about the plaque composition and vessel
healing. The use of IVUS, OCT and NIRS helps to clarify clinical
problems and to guide coronary intervention. It seems that
modern invasive cardiology should exploit more intravascular
imaging techniques on a daily clinical basis to improve
patients' outcomes.
Conﬂict of interest
No conﬂict of interest.
Ethical statement
Authors state that the research was conducted according to
ethical standards.
Acknowledgement
We thank Professor Michal Tendera for provided help during
the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Funding body
None.
r e f e r e n c e s
[1] P.G. Yock, D.T. Linker, Intravascular ultrasound. Looking below
the surface of vascular disease, Circulation 81 (1990) 1715–1718.
[2] A. Shiran, G.S. Mintz, B. Leiboff, et al., Serial volumetric
intravascular ultrasound assessment of arterial remodeling
in left main coronary artery disease, American Journal of
Cardiology 83 (1999) 1427–1432.
[3] M. Meine, A. Machraoui, G. Dasbach, et al., Intravascular
ultrasound ﬁndings in calcifying arteriosclerosis: in vitro
validation using ‘‘soft’’ roentgen images, Zeitschrift fur
Kardiologie 86 (1997) 818–826.
[4] S.J. Kang, G.S. Mintz, J. Pu, et al., Combined IVUS and NIRS
detection of ﬁbroatheromas: histopathological validation in
human coronary arteries, JACC Cardiovascula Imaging 8
(2015) 184–194.
[5] A. Nair, B.D. Kuban, E.M. Tuzcu, et al., Coronary plaque
classiﬁcation with intravascular ultrasound radiofrequency
data analysis, Circulation 106 (2002) 2200–2206.
[6] G.W. Stone, A. Maehara, A.J. Lansky, et al., A prospective
natural-history study of coronary atherosclerosis, New
England Journal of Medicine 364 (2011) 226–235.
[7] J.F. Granada, D. Wallace-Bradley, H.K. Win, et al., In vivo
plaque characterization using intravascular ultrasound-
virtual histology in a porcine model of complex coronary
lesions, Arteriosclerosis, Thrombosis, and Vascular Biology
27 (2007) 387–393.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 3 9 – e 4 4 5e444[8] C. Briguori, A. Anzuini, F. Airoldi, et al., Intravascular
ultrasound criteria for the assessment of the functional
signiﬁcance of intermediate coronary artery stenoses and
comparison with fractional ﬂow reserve, American Journal
of Cardiology 87 (2001) 136–141.
[9] R. Waksman, J. Legutko, J. Singh, et al., First: fractional ﬂow
reserve and intravascular ultrasound relationship study,
Journal of the American College of Cardiology 61 (2013)
917–923.
[10] P. Kolh, S. Windecker, F. Alfonso, et al., 2014 ESC/EACTS
guidelines on myocardial revascularization: the Task Force
on Myocardial Revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-
Thoracic Surgery (EACTS) developed with the special
contribution of the European Association of Percutaneous
Cardiovascular Interventions (EAPCI), European Heart
Journal 35 (2014) 2541–2619.
[11] F. Prati, T. Kodama, E. Romagnoli, et al., Suboptimal stent
deployment is associated with subacute stent thrombosis:
optical coherence tomography insights from a multicenter
matched study. From the CLI Foundation investigators:
The CLI-THRO study, American Heart Journal 169 (2015)
249–256.
[12] S.J. Kang, J.M. Ahn, H. Song, et al., Comprehensive
intravascular ultrasound assessment of stent area and its
impact on restenosis and adverse cardiac events in 403
patients with unprotected left main disease, Circulation:
Cardiovascular Interventions 4 (2011) 562–569.
[13] S.J. Park, Y.H. Kim, D.W. Park, et al., Impact of intravascular
ultrasound guidance on long-term mortality in stenting for
unprotected left main coronary artery stenosis, Circulation:
Cardiovascular Interventions 2 (2009) 167–177.
[14] H. Parise, A. Maehara, G.W. Stone, et al., Meta-analysis of
randomized studies comparing intravascular ultrasound
versus angiographic guidance of percutaneous coronary
intervention in pre-drug-eluting stent era, American
Journal of Cardiology 107 (2011) 374–382.
[15] B. Witzenbichler, A. Maehara, G. Weisz, et al., Relationship
between intravascular ultrasound guidance and clinical
outcomes after drug-eluting stents: the assessment of dual
antiplatelet therapy with drug-eluting stents (ADAPT-DES)
study, Circulation 129 (2014) 463–470.
[16] D. Huang, E.A. Swanson, C.P. Lin, et al., Optical coherence
tomography, Science 254 (1991) 1178–1181.
[17] F. Prati, M.W. Jenkins, A. Di Giorgio, A.M. Rollins,
Intracoronary optical coherence tomography, basic theory
and image acquisition techniques, International Journal of
Cardiovascular Imaging 27 (2011) 251–258.
[18] M. Choma, M. Sarunic, C. Yang, J. Izatt, Sensitivity
advantage of swept source and Fourier domain optical
coherence tomography, Optics Express 11 (2003) 2183–2189.
[19] T. Yamaguchi, M. Terashima, T. Akasaka, et al., Safety and
feasibility of an intravascular optical coherence
tomography image wire system in the clinical setting,
American Journal of Cardiology 101 (2008) 562–567.
[20] L.S. Athanasiou, C.V. Bourantas, P.K. Siogkas, et al., 3D
reconstruction of coronary arteries using frequency domain
optical coherence tomography images and biplane
angiography, in: Conf. Proc. IEEE Eng. Med. Biol. Soc., 2012,
2647–2650.
[21] H. Yabushita, B.E. Bouma, S.L. Houser, et al.,
Characterization of human atherosclerosis by optical
coherence tomography, Circulation 106 (2002) 1640–1645.
[22] J. Rieber, O. Meissner, G. Babaryka, et al., Diagnostic
accuracy of optical coherence tomography and
intravascular ultrasound for the detection and
characterization of atherosclerotic plaque composition in
ex-vivo coronary specimens: a comparison with histology,
Coronary Artery Disease 17 (2006) 425–430.[23] J. Narula, M. Nakano, R. Virmani, et al., Histopathologic
characteristics of atherosclerotic coronary disease and
implications of the ﬁndings for the invasive and
noninvasive detection of vulnerable plaques, Journal of the
American College of Cardiology 61 (2013) 1041–1051.
[24] H.G. Bezerra, M.A. Costa, G. Guagliumi, et al., Intracoronary
optical coherence tomography: a comprehensive review
clinical and research applications, JACC Cardiovascular
Interventions 2 (2009) 1035–1046.
[25] J. Gomez-Lara, M. Radu, S. Brugaletta, et al., Serial analysis
of the malapposed and uncovered struts of the new
generation of everolimus-eluting bioresorbable scaffold
with optical coherence tomography, JACC Cardiovascular
Interventions 4 (2011) 992–1001.
[26] A. Murata, D. Wallace-Bradley, A. Tellez, et al., Accuracy of
optical coherence tomography in the evaluation of
neointimal coverage after stent implantation, JACC
Cardiovascular Imaging 3 (2010) 76–84.
[27] T. Kubo, T. Imanishi, H. Kitabata, et al., Comparison of
vascular response after sirolimus-eluting stent
implantation between patients with unstable and stable
angina pectoris: a serial optical coherence tomography
study, JACC Cardiovasc. Imaging 1 (2008) 475–484.
[28] J.S. Kim, M.E. Afari, J. Ha, et al., Neointimal patterns
obtained by optical coherence tomography correlate with
speciﬁc histological components and neointimal
proliferation in a swine model of restenosis, European
Heart Journal: Cardiovascular Imaging 15 (2014) 292–298.
[29] F. Prati, S. Uemura, G. Souteyrand, et al., Oct-based
diagnosis and management of stemi associated with intact
ﬁbrous cap, JACC Cardiovascular Imaging 6 (2013) 283–287.
[30] P.R. Moreno, R.A. Lodder, K.R. Purushothaman, et al.,
Detection of lipid pool, thin ﬁbrous cap, and inﬂammatory
cells in human aortic atherosclerotic plaques by near-
infrared spectroscopy, Circulation 105 (2002) 923–927.
[31] Z.A. Ali, T. Roleder, J. Narula, et al., Increased thin-cap
neoatheroma and periprocedural myocardial infarction in
drug-eluting stent restenosis: multimodality intravascular
imaging of drug-eluting and bare-metal stents, Circulation:
Cardiovascular Interventions 6 (2013) 507–517.
[32] S. Waxman, S.R. Dixon, P. L'Allier, et al., In vivo validation
of a catheter-based near-infrared spectroscopy system for
detection of lipid core coronary plaques: initial results of
the spectacl study, JACC Cardiovascular Imaging 2 (2009)
858–868.
[33] A.S. Kini, U. Baber, J.C. Kovacic, et al., Changes in plaque
lipid content after short-term intensive versus standard
statin therapy: the yellow trial (reduction in yellow plaque
by aggressive lipid-lowering therapy), Journal of the
American College of Cardiology 62 (2013) 21–29.
[34] J.A. Goldstein, B. Maini, S.R. Dixon, et al., Detection of lipid-
core plaques by intracoronary near-infrared spectroscopy
identiﬁes high risk of periprocedural myocardial infarction,
Circulation: Cardiovascular Interventions 4 (2011) 429–437.
[35] G.W. Stone, A. Maehara, J.E. Muller, et al., Plaque
characterization to inform the prediction and prevention of
periprocedural myocardial infarction during percutaneous
coronary intervention: the canary trial (coronary assessment
by near-infrared of atherosclerotic rupture-prone yellow),
JACC Cardiovascular Interventions 8 (2015) 927–936.
[36] J. Pu, G.S. Mintz, E.S. Brilakis, et al., In vivo characterization
of coronary plaques: novel ﬁndings from comparing
greyscale and virtual histology intravascular ultrasound
and near-infrared spectroscopy, European Heart Journal 33
(2012) 372–383.
[37] T. Roleder, J.C. Kovacic, Z. Ali, et al., Combined NIRS and
IVUS imaging detects vulnerable plaque using a single
catheter system: a head-to-head comparison with OCT,
EuroIntervention 10 (2014) 303–311.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 4 3 9 – e 4 4 5 e445[38] N. Gonzalo, J. Escaned, F. Alfonso, et al., Morphometric
assessment of coronary stenosis relevance with optical
coherence tomography: a comparison with fractional ﬂow
reserve and intravascular ultrasound, Journal of the
American College of Cardiology 59 (2012) 1080–1089.
[39] T. Yonetsu, W. Suh, F. Abtahian, et al., Comparison of near-
infrared spectroscopy and optical coherence tomography
for detection of lipid, Catheter Cardiovascular Interventions
84 (2014) 710–717.
[40] S. Brugaletta, H.M. Garcia-Garcia, P.W. Serruys, et al., NIRS
and IVUS for characterization of atherosclerosis in patientsundergoing coronary angiography, JACC Cardiovascular
Imaging 4 (2011) 647–655.
[41] T. Sawada, J. Shite, H.M. Garcia-Garcia, et al., Feasibility of
combined use of intravascular ultrasound radiofrequency
data analysis and optical coherence tomography for
detecting thin-cap ﬁbroatheroma, European Heart Journal
29 (2008) 1136–1146.
[42] A.S. Kini, S. Motoyama, Y. Vengrenyuk, et al., Multimodality
intravascular imaging to predict periprocedural myocardial
infarction during percutaneous coronary intervention,
JACC Cardiovascular Interventions 8 (2015) 937–945.
